These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9009312)

  • 1. Role of aspartic proteases in disseminated Candida albicans infection in mice.
    Fallon K; Bausch K; Noonan J; Huguenel E; Tamburini P
    Infect Immun; 1997 Feb; 65(2):551-6. PubMed ID: 9009312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis.
    Schaller M; Korting HC; Schäfer W; Bastert J; Chen W; Hube B
    Mol Microbiol; 1999 Oct; 34(1):169-80. PubMed ID: 10540295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis.
    Puri S; Kumar R; Chadha S; Tati S; Conti HR; Hube B; Cullen PJ; Edgerton M
    PLoS One; 2012; 7(11):e46020. PubMed ID: 23139737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.
    Trabocchi A; Mannino C; Machetti F; De Bernardis F; Arancia S; Cauda R; Cassone A; Guarna A
    J Med Chem; 2010 Mar; 53(6):2502-9. PubMed ID: 20184325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis.
    Schaller M; Schackert C; Korting HC; Januschke E; Hube B
    J Invest Dermatol; 2000 Apr; 114(4):712-7. PubMed ID: 10733678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions.
    Consolaro ME; Gasparetto A; Svidzinski TI; Peralta RM
    Mycopathologia; 2006 Aug; 162(2):75-82. PubMed ID: 16897584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
    Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
    Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans.
    Morschhäuser J; Virkola R; Korhonen TK; Hacker J
    FEMS Microbiol Lett; 1997 Aug; 153(2):349-55. PubMed ID: 9271862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.
    Pericolini E; Gabrielli E; Amacker M; Kasper L; Roselletti E; Luciano E; Sabbatini S; Kaeser M; Moser C; Hube B; Vecchiarelli A; Cassone A
    mBio; 2015 Jun; 6(3):e00724. PubMed ID: 26037125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
    Schaller M; Korting HC; Borelli C; Hamm G; Hube B
    Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Candida albicans secreted aspartic proteinase in the development of candidoses.
    Hoegl L; Ollert M; Korting HC
    J Mol Med (Berl); 1996 Mar; 74(3):135-42. PubMed ID: 8846163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The secreted aspartic proteinases as a new target in the therapy of candidiasis.
    Bein M; Schaller M; Korting HC
    Curr Drug Targets; 2002 Oct; 3(5):351-7. PubMed ID: 12182226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.
    Backman D; Danielson UH
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):184-95. PubMed ID: 12637026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of a Candida albicans virulence gene family during infection.
    Staib P; Kretschmar M; Nichterlein T; Hof H; Morschhäuser J
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6102-7. PubMed ID: 10811913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors.
    Pichová I; Pavlícková L; Dostál J; Dolejsí E; Hrusková-Heidingsfeldová O; Weber J; Ruml T; Soucek M
    Eur J Biochem; 2001 May; 268(9):2669-77. PubMed ID: 11322888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted aspartic proteases as virulence factors of Candida species.
    Monod M; Borg-von ZM
    Biol Chem; 2002; 383(7-8):1087-93. PubMed ID: 12437091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.
    Borg-von Zepelin M; Meyer I; Thomssen R; Würzner R; Sanglard D; Telenti A; Monod M
    J Invest Dermatol; 1999 Nov; 113(5):747-51. PubMed ID: 10571729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis.
    Kretschmar M; Hube B; Bertsch T; Sanglard D; Merker R; Schröder M; Hof H; Nichterlein T
    Infect Immun; 1999 Dec; 67(12):6637-42. PubMed ID: 10569785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic protease.
    Aoki W; Kitahara N; Miura N; Morisaka H; Yamamoto Y; Kuroda K; Ueda M
    PLoS One; 2012; 7(2):e32513. PubMed ID: 22384266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of pepstatin A on Candida albicans infection in the mouse].
    Zotter C; Haustein UF; Schönborn C; Grimmecke HD; Wand H
    Dermatol Monatsschr; 1990; 176(2-3):189-98. PubMed ID: 2194852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.